Resumen de: US20260256386A1
A system and method for monitoring pH of an intraoral device involves receiving the oral pH data from at least one pH sensor embedded within the intraoral device. The oral pH data is then correlated with one or more user related data to classify the oral pH data into one or more pre-defined categories indicative of a health condition. Further, the machine learning module generates feedback and/or recommendations for the user based on the classification of the oral pH data into one or more pre-defined categories. The oral pH data and/or feedback and/or recommendations are then communicated to the user and/or external device.
Resumen de: US20260256546A1
A system comprises an intraoral scanner, a three-dimensional (3D) image capture device, and a computing device operatively coupled to the intraoral scanner and to the 3D image capture device. The computing device receives intraoral scan data of a dental site of a patient generated by the intraoral scanner during intraoral scanning. The computing device further receives one or more 3D images of a face of the patient generated by the 3D image capture device during the intraoral scanning, wherein the intraoral scanner is captured in the one or more 3D images. The computing device registers the one or more 3D images of the face of the patient to the first intraoral scan data based at least in part on a first position of the intraoral scanner relative to the face of the patient in the one or more 3D images.
Resumen de: US20260256547A1
0000 The present invention relates to a clear orthodontic aligner comprising at least one molecule capable of changing color or color intensity (CCM). Furthermore, the invention relates to a process for obtaining a clear orthodontic aligner by means of three-dimensional (3D) printing.
Resumen de: US20260260729A1
0000 Systems and methods are provided for identifying therapeutic zones where there is glycemic dysfunction of a specific type that can be addressed by making strategic changes to behavior and/or therapy parameters. Systems and methods described herein evaluate large historical data sets to: identify a therapeutic zone or zones with glycemic dysfunction that are most readily addressable; quantify the glycemic impact of a plurality of different therapeutic adjustments in terms of either adjustments to historical doses or the parameters of a prospective dosing strategy to determine the highest possible improvement; and/or identify patient dosing strategies to provide therapy recommendations adapted for the patient’s preferred behavioral dosing strategy.
Resumen de: US20260256559A1
A three-dimensional printing composition includes: a polymerizable monomer; inorganic particles; and a photopolymerization initiator. The inorganic particles are surface-treated with a compound represented by a general formula (1)(in the general formula, R1 is a hydrogen atom or a methyl group; R2 is a hydrolyzable group; R3 is a hydrocarbon group having 1 or more and 6 or less carbon atoms; p is 2 or 3; and q is an integer of 5 or more and 13 or less).
Resumen de: US20260256592A1
0000 A system and method for improving upon an ability of a surgeon to repair traumatic bone injury using new materials, components, and structures. A structure may be used as an implant or a component of an external fixator for a fractured long bone with that structure having anisotropic and viscoelastic properties, such as through additive manufacturing techniques.
Resumen de: WO2026180764A1
The invention relates to a bioink for 3D printing of a scaffold (1) suitable for corneal tissue regeneration, composed of sodium alginate, aldehyde hyaluronic acid, N,O-carboxymethyl chitosan and collagen I, where the collagen I undergoes a preliminary neutralisation process using sodium hydroxide. The present invention also describes a method for the 3D printing of a scaffold (1) suitable for corneal tissue regeneration and a method for sterilising same using ethylene oxide (EtO).
Resumen de: EP4799658A1
0001 The present disclosure relates to a dry implant suitable for rehydration before placement in a human or animal body.
Resumen de: EP4799549A1
0001 An exemplary aspect is generally directed to generating various compositions of input video information for streaming to one or more displays. For example, a first display can be configured to show a first video stream and a second video stream. The first video stream can be a live view of video from an endoscope, and the second video stream can be from a (remote) camera control unit. These streams are presented in a PIP (Picture-in-Picture) mode, or in a PAP (Picture-and-Picture) mode. Any of the video streams or other information are selectable for display and any combination thereof is selectably configured for streaming to any selected display. Additional aspects relate to a video rendering system where the dominant image is a 3D image stream and the subordinate image (such as in PiP) is the same image stream, but in 2D. Even more aspects relate to a video rendering system where the dominant image is a 2D image stream and the subordinate image is the same image stream, but in 3D.
Resumen de: EP4800706A1
A mind-body state intervention apparatus (100) includes a physiological amount acquirer (110) that acquires a physiological amount of a subject detected by a physiological amount detector (160); a quantification processor (120) that quantifies, for a predetermined mind-body state, two mind-body states based on the physiological amount, the two mind-body states including a mind-body state that the subject is aware of and a mind-body state that the subject is unaware of; a first storage (130) that stores relational data in advance, the relational data indicating relationships between each of multiple intervention control schemes and intervention effects on the two mind-body states quantified; and an intervention controller (140) that performs intervention control in which, with reference to the relational data, one intervention control scheme is selected from among the multiple intervention control schemes, based on the intervention effect on at least one of the two mind-body states quantified by the quantification processor (120), and intervention equipment (150) is controlled in accordance with the selected intervention control scheme.
Resumen de: WO2025088142A1
The invention relates to a method for volumetric additive manufacturing (VAM) using holography for 3D printing an object, and a corresponding VAM system. The method includes determining a composite hologram, and performing a phase and/or spatial light modulating of a coherent input beam, such as a laser, based on the composite hologram and directing the spatially and/or phase modulated beam towards the reconstruction space to generate a pixelated projection in the reconstruction space, the pixelated projection being applied for printing the 3D object, for example using a photocurable resin. The invention provides improved resolution, speed, and/or light efficiency, in particular with respect to 3D printing of biological/medical objects, such as biocompatible implants, such as organs or parts of organs.
Resumen de: WO2025091008A1
Described herein are methods of use involving tissue mimicking compositions comprising hydrogel systems and at least one therapeutic agent
Resumen de: WO2025090560A1
Methods for selective matting of some, but not all, surfaces of a silicone article of manufacture are disclosed. By use of a silicone matting additive and manipulation of process variables, a silicone article of manufacture may be produced that comprises some surface areas that exhibit silicone's inherent tacky texture and other surface areas that exhibit a matted texture. In an exemplary embodiment, a silicone prosthetic liner may be produced where an interior surface is taky and an exterior surface is matted.
Resumen de: EP4800705A2
Systems and methods for a continuous monitoring of analyte values received from an analyte sensor system are provided. One method for a wireless data communication between an analyte sensor system and a mobile device involves storing identification information associated with a transceiver of the analyte sensor system, the identification information entered by a user of the mobile device via a custom application running on the mobile device; causing the custom application to enter a background mode; searching for advertisement signals; receiving an advertisement signal from the transceiver; authenticating the transceiver based on the identification information; prompting the user to bring the custom application to a foreground mode; causing the custom application to request a confirmation from the user that a data connection with the transceiver is desired; receiving the confirmation from the user; and completing the data connection with the transceiver.
Resumen de: GB2645211A
The present invention relates to medical devices for dental practices. The invention develops a smart high speed dental handpiece used for cutting into the hard structures of the teeth for different dental treatments intended to improve the overall quality of treatment with less fatigue to the operating dental professionals, the digital dental handpiece comprising a dental handpiece, an optical insert and a video camera adapter, The present invention designed to enhance real time visibility, ergonomics, and functionality during high-speed dental procedures.
Resumen de: EP4800534A2
The subject matter disclosed herein provides methods for presenting glucose level data. Glucose data for a patient may be received. A current glucose level and a rate of change of the current glucose level may be determined based on the received glucose data. A first interface may be displayed on a screen of a device. The first interface may include a unitary icon. The unitary icon may display the current glucose level and a visualization of the rate of change. Related apparatus, systems, techniques, and articles are also described.
Resumen de: EP4799670A2
0001 The present invention relates to a combined one way inspiratory valve and expiratory release valve assembly, for controlling air flow in a respiratory treatment system for delivering pressurised air to an entrance to a patient's airways, the system being configured to maintain a therapy pressure in a range suitable for treating respiratory disorders. The combined valve assembly comprises a housing comprising a valve inlet, a valve outlet and at least one vent opening and, a diaphragm sealingly connected to the housing at an outer circumference of the diaphragm. The diaphragm divides the housing into: a) an upstream portion, which is in fluid communication with the valve inlet; and b) a downstream portion which is in fluid communication with the valve outlet, and wherein the diaphragm has an oval shape having no more than a single axis of symmetry. The inner portion of the diaphragm defines a one way inspiratory valve configured to a) allow flow from the valve inlet to the valve outlet when the pressure in the upstream portion of the housing exceeds the pressure in the downstream portion of the housing; and b) reduce or substantially prevent flow from the valve inlet to the valve outlet when the pressure in the downstream portion is greater than the pressure in the upstream portion. The outer portion of the diaphragm defines an expiratory release valve that a) when the pressure in the downstream portion exceeds the pressure in the upstream portion, allows flow from the
Resumen de: EP4800695A2
0001 Techniques for performing application-layer security and communication over primary invitation channels are disclosed. In certain embodiments, analyte data is obtained from an analyte sensor electrically coupled to a sensor electronics module of an analyte sensor system. A secret key is established with a display device over one or more primary invitation channels. The analyte data is encrypted using the secret key. The encrypted analyte data is broadcast over the one or more primary invitation channels.
Resumen de: EP4799571A2
The present invention relates to a patient interface comprising a plenum chamber pressurisable to a therapeutic pressure of at least 6 cmH2O above ambient air pressure, said plenum chamber including a plenum chamber inlet port sized and structured to receive a flow of air at the therapeutic pressure for breathing by a patient; and a seal-forming structure constructed and arranged to form a seal with a region of the patient's face surrounding an entrance to the patient's airways, said seal-forming structure having a hole therein such that the flow of air at said therapeutic pressure is delivered to at least an entrance to the patient's nares, the seal-forming structure constructed and arranged to maintain said therapeutic pressure in the plenum chamber throughout the patient's respiratory cycle in use. The patient interface further comprises a positioning and stabilising structure to provide a force to hold the seal-forming structure in a therapeutically effective position on the patient's head; one or more electronic components for monitoring, diagnosing and/or treating the patient, the one or more electronic components being provided in, or on, one or more of the plenum chamber, the seal-forming structure and the positioning and stabilising structure; and a power system for converting energy generated during use of the patient interface to electrical energy for powering the one or more electronic components, wherein the energy generated during use of the patient i
Resumen de: EP4799586A2
0001 The present disclosure provides apparatuses and methods for measurement of the biocapacitance of tissue. The apparatus comprises a sensor comprising two electrodes, a movable element coupled to the sensor, and a switch disposed between the movable element and a fixed element, wherein the switch electrically closes when a gap between the movable element and the fixed element is less than or equal to a pre-determined value. The device makes a measurement of the biocapacitance between the two electrodes when the switch closes.
Resumen de: WO2025088134A1
The present invention relates to a dental abutment and assembly for anchoring a dental appliance comprising means addressing, by allowing lateral and angular movements, deviation from tolerance generated at an interface between the dental abutment and a dental appliance produced by additive or subtractive manufacturing.
Resumen de: JP2026139391A
0001 【課題】薬剤が収納された分包袋の監査支援処理を効率良く行い得るようにする。 【解決手段】薬剤監査支援装置1は、薬剤監査支援処理を行う場合、分包袋連続体100に含まれる検薬包120の位置や順序をユーザに指定させる。薬剤監査支援装置1は、監査処理において、検薬包120を除いた残りの分包袋110から基準包140を決定し、その薬剤数である基準薬剤数を、検薬包120を除いた各分包袋110の薬剤数と比較し、その結果を基にそれぞれの分包袋状態を決定する。これにより薬剤監査支援装置1は、検薬包120に起因する誤った監査結果を得ることがなく、適切に決定された基準包140に基づいた精度の高い監査結果を得ることができる。 【選択図】図12
Resumen de: CN122665183A
本发明属于生物医学工程与组织工程材料技术领域,具体涉及一种超声响应性导电复合水凝胶及其在心肌梗死治疗中的应用。本发明提供的复合水凝胶包括氧化透明质酸修饰硒纳米颗粒、壳聚糖、甲基丙烯酰化明胶、氧化石墨烯和光引发剂,经数字光处理打印成型。该材料能够在心肌梗死后偏酸性微环境中实现水凝胶网络的可控疏松与含硒纳米颗粒的持续释放,并可在低强度治疗超声刺激下进一步增强含硒纳米颗粒的按需释放;释放的含硒纳米颗粒用于补充局部硒相关抗氧化防御、抑制脂质过氧化与铁死亡,氧化石墨烯导电网络则可用于改善受损区域电信号传导,从而协同促进心肌梗死后心肌结构、细胞电耦联和心功能修复。
Resumen de: CN122665198A
本发明公开了一种人体仿生骨支架的制备方法,属于生物医用材料及增材制造技术领域,包括以下步骤:S1.制备光固化浆料;S2.采用数字光处理(DLP)3D打印技术,将步骤S1的浆料逐层固化成型,得到生坯支架;S3.对生坯支架进行脱脂和烧结,制得人体仿生骨支架。与现有技术相比,本发明优化了β‑TCP与阿克曼石的复合比例,在10%~30%体积含量的β‑TCP范围内,浆料表现出假塑性流体和剪切稀化特征,适于DLP打印。特别是30%β‑TCP组别在高速剪切下粘度最大,屈服剪切应力最高,有利于打印后的形状保持。本发明通过精确控制脱脂烧结工艺,有效避免了因粘结剂快速分解产生气体导致的开裂和缺陷,获得了高纯度复合陶瓷支架。
Nº publicación: CN224699285U 01/09/2026
Solicitante:
上海陈信医疗器械有限公司
Resumen de: CN224699285U
本申请公开了一种3D打印多系统种植取螺丝套件,涉及3D打印领域,其包括着床块,所述着床块的上表面固定安装有定位块,所述定位块的上表面固定安装有螺纹块,所述螺纹块的上表面固定安装有假牙嵌入块,所述定位块的轴心处开设有定位插孔,所述螺纹块内开设有螺旋槽,所述螺旋槽的圆周侧壁设置有紧固螺纹,所述假牙嵌入块的上表面开设有凹槽,所述定位插孔、螺旋槽以及凹槽相连通且呈同轴设置。本装置通过3D打印技术一体成型,一体成型结构提升了套件的整体强度和稳定性,减少装配误差,确保取螺丝过程中力的有效传递,降低部件断裂风险,此外,各部件尺寸设计覆盖多种种植体和螺丝规格,适配性强,可满足多系统种植场景需求,减少工具更换频率。